Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL483479 | 0.79 | ALDH1A1 (0.31) | — | |
| SCHEMBL9193708 | 0.76 | OPRM1 (0.38) | OPRM1TP53 | |
| SCHEMBL5358887 | 0.75 | OPRM1 (0.50) | OPRM1SPHK1TP53 | |
| SCHEMBL28622632 | 0.73 | OPRM1 (0.52) | OPRM1SPHK1TP53 | |
| SCHEMBL16038562 | 0.73 | OPRM1 (0.46) | OPRM1SPHK1TP53 | |
| Water SCHEMBL18549323 | 0.73 | OPRM1 (0.48) | OPRM1SPHK1TP53 | |
| SCHEMBL20574319 | 0.71 | — | — | |
| Ammonia Solution, Strong SCHEMBL3735754 | 0.71 | — | — | |
| SCHEMBL906667 | 0.71 | CYP3A4 (0.46) | OPRM1 | |
| SCHEMBL24392963 | 0.71 | OPRM1 (0.59) | OPRM1SPHK1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545809-B2 | Moisture-curing conformal coating compositions | WACKER CHEMIE AG (DE) | 2026-02-10 | — | — | US | disclosed |
| US-20230279263-A1 | MOISTURE-CURING CONFORMAL COATING COMPOSITIONS | WACKER CHEMIE AG (DE) | 2023-09-07 | — | — | US | disclosed |
| EP-4172246-A1 | MOISTURE-CURING CONFORMAL COATING COMPOSITIONS | Wacker Chemie AG (DE) | 2023-05-03 | — | — | EP | disclosed |
| CN-115702188-A | Moisture-curable conformal coating composition | 瓦克化学股份公司 | 2023-02-14 | — | — | CN | disclosed |
| WO-2021259460-A1 | MOISTURE-CURING CONFORMAL COATING COMPOSITIONS | WACKER CHEMIE AG (DE) | 2021-12-30 | — | — | WO | disclosed |
| EP-0197540-B1 | USE OF AMINES FOR STABILIZING POLYSILOXANE FLUIDS | WACKER-CHEMIE GMBH (DE) | 1991-11-13 | — | — | EP | disclosed |
| US-4933414-A | Radiation active silicon compounds having amide limited mercaptan functional groups | GENERAL ELECTRIC COMPANY (US) | 1990-06-12 | — | — | US | disclosed |
| US-4783490-A | Radiation active silicon compounds having amide limited mercaptan functional groups | GENERAL ELECTRIC COMPANY (US) | 1988-11-08 | — | — | US | disclosed |
| US-4644074-A | AGAINST DEGRADATION BY KAOLIN CLAY BY ADDING AN AMINE | SWS SILICONES CORPORATION (US) | 1987-02-17 | — | — | US | disclosed |
| EP-0197540-A2 | Use of amines for stabilizing polysiloxane fluids | WACKER-CHEMIE GMBH (DE) | 1986-10-15 | — | — | EP | disclosed |
| US-4612055-A | Stabilized blends of thiofunctional polysiloxane fluids and organopolysiloxane fluids and a process for stabilizing the same | SWS SILICONES CORPORATION (US) | 1986-09-16 | — | — | US | disclosed |
| US-4588771-A | Stabilized thiofunctional polysiloxane fluids and a process for stabilizing the same | SWS SILICONES CORPORATION (US) | 1986-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545809-B2 | Moisture-curing conformal coating compositions | COL1A1, COL2A1, MSR1 | OPRM1 400/4885SPHK1 4584/4885TP53 2363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.